The table below compares all 300 Specialty Finance companies on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IX | Orix Corp | primary | F-06 | Lending and Credit | FG-02 | 43.58 Bn | 10.86 | 1.94 | 43.58 Bn |
| 2 | RPRX | Royalty Pharma plc | primary | F-06 | Lending and Credit | FG-02 | 26.96 Bn | 19.97 | 10.63 | 26.12 Bn |
| 3 | RGLD | Royal Gold Inc | primary | F-06 | Lending and Credit | FG-02 | 22.24 Bn | 29.86 | 14.38 | 22.06 Bn |
| 4 | OR | OR Royalties Inc. | primary | F-06 | Lending and Credit | FG-02 | 6.98 Bn | 18.46 | 19.24 | 6.90 Bn |
| 5 | ECPG | Encore Capital Group Inc | primary | F-06 | Lending and Credit | FG-02 | 2.11 Bn | 7.00 | 1.11 | 1.93 Bn |
| 6 | ATLC | Atlanticus Holdings Corp | primary | F-06 | Lending and Credit | FG-02 | 1.41 Bn | 9.71 | 0.53 | 0.85 Bn |
| 7 | JCAP | Jefferson Capital, Inc. / DE | primary | F-06 | Lending and Credit | FG-02 | 1.20 Bn | 8.21 | 1.88 | 1.18 Bn |
| 8 | UPBD | Upbound Group, Inc. | primary | F-06 | Lending and Credit | FG-02 | 1.06 Bn | 11.75 | 0.22 | 0.96 Bn |
| 9 | LU | Lufax Holding Ltd | primary | F-06 | Lending and Credit | FG-02 | 1.05 Bn | -2.06 | 0.29 | -1.58 Bn |
| 10 | BUR | Burford Capital Ltd | primary | F-06 | Lending and Credit | FG-02 | 0.98 Bn | -0.58 | 0.50 | 0.98 Bn |
| 11 | MTA | Metalla Royalty & Streaming Ltd. | primary | F-06 | Lending and Credit | FG-02 | 0.96 Bn | -553.88 | — | 0.95 Bn |
| 12 | PRAA | Pra Group Inc | primary | F-06 | Lending and Credit | FG-02 | 0.73 Bn | -2.89 | 0.55 | 0.60 Bn |
| 13 | UROY | Uranium Royalty Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.62 Bn | 226.39 | 15.65 | 0.52 Bn |
| 14 | GROY | Gold Royalty Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.58 Bn | 180.86 | 25.56 | 0.56 Bn |
| 15 | OPFI | OppFi Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.51 Bn | 2.77 | 1.40 | 0.42 Bn |
| 16 | ORBS | Eightco Holdings Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.42 Bn | -1.59 | 16.60 | 0.35 Bn |
| 17 | ALUB-UN | Alussa Energy Acquisition Corp. II | primary | F-06 | Lending and Credit | FG-02 | 0.37 Bn | 103.23 | — | 0.37 Bn |
| 18 | SWKHL | SWK Holdings Corp | primary | F-06 | Lending and Credit | FG-02 | 0.31 Bn | -333.28 | 7.49 | 0.27 Bn |
| 19 | TROO | Troops, Inc. /Cayman Islands/ | primary | F-06 | Lending and Credit | FG-02 | 0.26 Bn | -9.35 | 16.01 | 0.25 Bn |
| 20 | SUIG | SUI Group Holdings Ltd. | primary | F-06 | Lending and Credit | FG-02 | 0.08 Bn | -0.28 | 26.37 | 0.08 Bn |
| 21 | MGTE | Marblegate Capital Corp | primary | F-06 | Lending and Credit | FG-02 | 0.07 Bn | -1.63 | 1.21 | 0.06 Bn |
| 22 | ICRP | InPoint Commercial Real Estate Income, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.06 Bn | -3.17 | 2.59 | 0.00 Bn |
| 23 | RMCO | Royalty Management Holding Corp | primary | F-06 | Lending and Credit | FG-02 | 0.04 Bn | -344.09 | 7.22 | 0.04 Bn |
| 24 | BMNM | Bimini Capital Management, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.03 Bn | 5.30 | 1.28 | 0.03 Bn |
| 25 | ZLME | Zhanling International Ltd | primary | F-06 | Lending and Credit | FG-02 | 0.03 Bn | -721.26 | — | 0.03 Bn |
| 26 | ABCP | AmBase Corp | primary | F-06 | Lending and Credit | FG-02 | 0.02 Bn | -8.94 | — | 0.02 Bn |
| 27 | STQN | Strategic Acquisitions Inc /Nv/ | primary | F-06 | Lending and Credit | FG-02 | 0.02 Bn | -131.82 | — | 0.02 Bn |
| 28 | KARX | Karbon-X Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -1.11 | 0.23 | 0.01 Bn |
| 29 | SPST | Superstar Platforms Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -22.51 | — | 0.01 Bn |
| 30 | AIHS | Senmiao Technology Ltd | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -0.27 | 5.15 | 0.00 Bn |
| 31 | SPFX | Standard Premium Finance Holdings, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | 7.06 | 0.69 | 0.01 Bn |
| 32 | SUND | Sundance Strategies, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | — | — | 0.01 Bn |
| 33 | TCRI | TechCom, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.01 Bn | -111.02 | — | 0.01 Bn |
| 34 | SRCO | Sparta Commercial Services, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -1.26 | 12.42 | 0.01 Bn |
| 35 | BENF | Beneficient | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.04 | 0.06 | 0.00 Bn |
| 36 | DEVSF | DevvStream Corp. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.25 | 86.12 | 0.00 Bn |
| 37 | SHFS | SHF Holdings, Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.22 | 0.14 | 0.00 Bn |
| 38 | QPRC | Quest Patent Research Corp | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.09 | 0.28 | 0.00 Bn |
| 39 | FTFT | Future FinTech Group Inc. | primary | F-06 | Lending and Credit | FG-02 | 0.00 Bn | -0.16 | 0.26 | 0.00 Bn |
| 40 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 643.26 Bn | 30.58 | 6.57 | 622.50 Bn |
| 41 | ABBV | AbbVie Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 443.31 Bn | 70.19 | 6.89 | 436.74 Bn |
| 42 | CAT | Caterpillar Inc | secondary | I-05 | Machinery | IG-02 | 376.30 Bn | 34.70 | 5.04 | 369.59 Bn |
| 43 | MRK | Merck & Co., Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 364.74 Bn | 115.10 | 5.48 | 357.60 Bn |
| 44 | MBFJF | Mitsubishi Ufj Financial Group Inc | secondary | F-02 | Banking | FG-01 | 296.69 Bn | 18.42 | 5.61 | -87.63 Bn |
| 45 | NVS | Novartis Ag | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 266.46 Bn | 9.25 | 3.88 | 258.77 Bn |
| 46 | TOYOF | Toyota Motor Corp/ | secondary | D-01 | Automobiles and Components | DG-01 | 256.51 Bn | 8.85 | 0.77 | 178.52 Bn |
| 47 | IBM | International Business Machines Corp | secondary | T-43 | Cloud Computing | TG-07 | 226.49 Bn | 21.12 | 3.28 | 215.13 Bn |
| 48 | DE | Deere & Co | secondary | I-06 | Machinery | IG-02 | 182.65 Bn | 40.13 | 3.81 | 173.72 Bn |
| 49 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 180.92 Bn | -62.49 | 5.94 | 177.74 Bn |
| 50 | BBVA | Banco Bilbao Vizcaya Argentaria, S.A. | secondary | F-02 | Banking | FG-01 | 167.33 Bn | 12.91 | — | 167.33 Bn |
| 51 | PFE | Pfizer Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 158.57 Bn | 36.30 | 2.49 | 146.88 Bn |
| 52 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.16 Bn | 30.00 | 10.50 | 124.30 Bn |
| 53 | HMC | Honda Motor Co Ltd | secondary | D-01 | Automobiles and Components | DG-01 | 125.19 Bn | 65.71 | 1.14 | 85.06 Bn |
| 54 | SMFG | Sumitomo Mitsui Financial Group, Inc. | secondary | F-02 | Banking | FG-01 | 101.25 Bn | 8.70 | -90.47 | 101.25 Bn |
| 55 | HPE | Hewlett Packard Enterprise Co | secondary | T-12 | Computer Hardware | TG-02 | 78.50 Bn | 29.34 | 1.87 | 72.28 Bn |
| 56 | PCAR | Paccar Inc | secondary | I-05 | Machinery | IG-02 | 64.20 Bn | 25.64 | 2.31 | 55.53 Bn |
| 57 | AJG | Arthur J. Gallagher & Co. | secondary | F-16 | Insurance | FG-04 | 62.74 Bn | 39.84 | 3.98 | 61.35 Bn |
| 58 | O | Realty Income Corp | secondary | R-06 | Property REITs | RG-01 | 56.12 Bn | 44.27 | 9.27 | 56.12 Bn |
| 59 | SNY | Sanofi | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 52.33 Bn | 11.23 | 0.98 | 44.95 Bn |
| 60 | PSA | Public Storage | secondary | R-08 | Property REITs | RG-01 | 51.71 Bn | 28.02 | 10.57 | 51.45 Bn |
| 61 | FITB | Fifth Third Bancorp | secondary | F-01 | Banking | FG-01 | 49.43 Bn | 18.58 | 4.87 | 25.71 Bn |
| 62 | MSTR | Strategy Inc | secondary | T-23 | Business Applications | TG-03 | 46.87 Bn | -1.49 | 94.05 | 44.42 Bn |
| 63 | RVMD | Revolution Medicines, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 43.79 Bn | -24.76 | — | 43.79 Bn |
| 64 | TEVA | Teva Pharmaceutical Industries Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 42.84 Bn | 61.56 | 2.47 | 39.19 Bn |
| 65 | MTB | M&T Bank Corp | secondary | F-01 | Banking | FG-01 | 34.72 Bn | 12.08 | 3.49 | 34.72 Bn |
| 66 | ALC | Alcon Inc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 33.70 Bn | 52.41 | 3.13 | 32.24 Bn |
| 67 | HBAN | Huntington Bancshares Inc /Md/ | secondary | F-01 | Banking | FG-01 | 33.60 Bn | 14.96 | 3.46 | 29.07 Bn |
| 68 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.05 Bn | -20.25 | 2,751.33 | 30.05 Bn |
| 69 | BAP | Credicorp Ltd | secondary | F-02 | Banking | FG-01 | 29.80 Bn | 3.36 | — | 29.80 Bn |
| 70 | GEHC | GE HealthCare Technologies Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 29.54 Bn | 14.41 | 1.39 | 27.44 Bn |
| 71 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.99 Bn | -31.97 | 24.60 | 26.83 Bn |
| 72 | CINF | Cincinnati Financial Corp | secondary | F-13 | Insurance | FG-04 | 26.05 Bn | 8.03 | 1.87 | 24.15 Bn |
| 73 | SYF | Synchrony Financial | secondary | F-04 | Lending and Credit | FG-02 | 25.68 Bn | 7.48 | 1.32 | 9.49 Bn |
| 74 | RF | Regions Financial Corp | secondary | F-01 | Banking | FG-01 | 25.53 Bn | 11.88 | 3.35 | 25.53 Bn |
| 75 | INCY | Incyte Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 25.23 Bn | 15.65 | 4.34 | 20.69 Bn |
| 76 | FCNCA | First Citizens Bancshares Inc /De/ | secondary | F-01 | Banking | FG-01 | 24.60 Bn | 10.85 | 89.45 | 24.07 Bn |
| 77 | AER | AerCap Holdings N.V. | secondary | I-01 | Aerospace and Defense | IG-01 | 24.34 Bn | 5.76 | 2.72 | 24.34 Bn |
| 78 | KEY | Keycorp /New/ | secondary | F-01 | Banking | FG-01 | 23.26 Bn | 12.33 | 2.99 | -24.44 Bn |
| 79 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.67 Bn | 16.53 | 6.87 | 19.01 Bn |
| 80 | SNX | Td Synnex Corp | secondary | T-64 | Technology Services | TG-11 | 20.62 Bn | 18.14 | 0.30 | 19.52 Bn |
| 81 | SNA | Snap-on Inc | secondary | I-08 | Machinery | IG-02 | 19.54 Bn | 18.46 | 3.70 | 17.89 Bn |
| 82 | LEN | Lennar Corp /New/ | secondary | D-08 | Homebuilding | DG-03 | 19.43 Bn | 9.72 | 0.59 | 17.25 Bn |
| 83 | VTRS | Viatris Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 19.13 Bn | -46.58 | 1.30 | 18.24 Bn |
| 84 | FTAI | FTAI Aviation Ltd. | secondary | I-01 | Aerospace and Defense | IG-01 | 19.00 Bn | 39.78 | 6.10 | 18.66 Bn |
| 85 | CNH | CNH Industrial N.V. | secondary | I-06 | Machinery | IG-02 | 17.18 Bn | 66.07 | 0.94 | 15.31 Bn |
| 86 | CBSH | Commerce Bancshares Inc /Mo/ | secondary | F-01 | Banking | FG-01 | 16.74 Bn | 28.33 | 8.97 | 16.53 Bn |
| 87 | ZTO | ZTO Express (Cayman) Inc. | secondary | I-23 | Transportation | IG-05 | 16.53 Bn | 11.12 | 2.12 | 11.93 Bn |
| 88 | KIM | Kimco Realty Corp | secondary | R-03 | Property REITs | RG-01 | 15.83 Bn | 27.53 | 7.35 | 15.83 Bn |
| 89 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.65 Bn | 22.19 | 4.64 | 15.26 Bn |
| 90 | JAZZ | Jazz Pharmaceuticals plc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.22 Bn | 16.17 | 3.31 | 13.60 Bn |
| 91 | PNFP | Pinnacle Financial Partners, Inc. | secondary | F-01 | Banking | FG-01 | 14.98 Bn | 20.27 | 13.44 | 7.33 Bn |
| 92 | EXEL | Exelixis, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 14.62 Bn | 16.98 | 6.00 | 13.78 Bn |
| 93 | BWXT | BWX Technologies, Inc. | secondary | I-39 | Clean Energy Equipment | IG-10 | 14.38 Bn | 40.38 | 4.09 | 13.77 Bn |
| 94 | TXT | Textron Inc | secondary | I-01 | Aerospace and Defense | IG-01 | 13.90 Bn | 14.83 | 0.91 | 12.46 Bn |
| 95 | AIZ | Assurant, Inc. | secondary | F-13 | Insurance | FG-04 | 13.89 Bn | 13.06 | 1.03 | 11.86 Bn |
| 96 | ALLY | Ally Financial Inc. | secondary | F-02 | Banking | FG-01 | 12.95 Bn | 9.74 | 1.49 | 5.11 Bn |
| 97 | CORT | Corcept Therapeutics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 12.16 Bn | 224.28 | 14.63 | 11.85 Bn |
| 98 | JEF | Jefferies Financial Group Inc. | secondary | F-17 | Capital Markets | FG-05 | 11.66 Bn | 14.63 | 0.98 | -3.79 Bn |
| 99 | KYMR | Kymera Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 11.32 Bn | -37.78 | 107.81 | 10.63 Bn |
| 100 | AXSM | Axsome Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 10.89 Bn | -70.84 | 14.02 | 10.57 Bn |
| 101 | GKOS | GLAUKOS Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 10.58 Bn | -67.15 | 17.26 | 10.46 Bn |
| 102 | SSB | SouthState Bank Corp | secondary | F-01 | Banking | FG-01 | 10.25 Bn | 10.79 | 35.78 | 7.88 Bn |
| 103 | WTFC | Wintrust Financial Corp | secondary | F-01 | Banking | FG-01 | 10.15 Bn | 11.97 | 3.54 | -62.03 Bn |
| 104 | CFR | Cullen/Frost Bankers, Inc. | secondary | F-01 | Banking | FG-01 | 10.12 Bn | 14.94 | 77.74 | 3.61 Bn |
| 105 | PRAX | Praxis Precision Medicines, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 10.05 Bn | -26.35 | — | 9.29 Bn |
| 106 | FCFS | FirstCash Holdings, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 10.00 Bn | 25.77 | 2.43 | 9.83 Bn |
| 107 | CYTK | Cytokinetics Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.79 Bn | -13.35 | 144.68 | 8.62 Bn |
| 108 | NUVL | Nuvalent, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 9.75 Bn | -27.07 | — | 9.75 Bn |
| 109 | AVB | Avalonbay Communities Inc | secondary | R-01 | Property REITs | RG-01 | 9.67 Bn | 9.28 | 3.14 | 9.87 Bn |
| 110 | AGCO | Agco Corp /De | secondary | I-06 | Machinery | IG-02 | 9.03 Bn | 18.72 | 0.87 | 8.45 Bn |
| 111 | CRNX | Crinetics Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.99 Bn | -17.90 | 213.22 | 8.99 Bn |
| 112 | GPCR | Structure Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 8.96 Bn | -47.63 | — | 8.96 Bn |
| 113 | LAD | Lithia Motors Inc | secondary | D-37 | Retail | DG-10 | 8.24 Bn | 11.45 | 0.22 | 7.88 Bn |
| 114 | VLY | Valley National Bancorp | secondary | F-01 | Banking | FG-01 | 7.61 Bn | 11.46 | 105.76 | 7.27 Bn |
| 115 | ALKS | Alkermes plc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 7.58 Bn | 114.56 | 4.54 | 6.92 Bn |
| 116 | FAF | First American Financial Corp | secondary | F-14 | Insurance | FG-04 | 7.35 Bn | 9.84 | 0.92 | 4.23 Bn |
| 117 | TEX | Terex Corp | secondary | I-05 | Machinery | IG-02 | 7.05 Bn | 47.32 | 1.06 | 6.64 Bn |
| 118 | BLCO | Bausch & Lomb Corp | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 6.33 Bn | -38.86 | 1.19 | 5.96 Bn |
| 119 | BLRX | BioLineRx Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 6.31 Bn | -704.68 | 4,533.84 | 6.31 Bn |
| 120 | GATX | Gatx Corp | secondary | I-11 | Machinery | IG-02 | 6.30 Bn | 26.82 | 3.07 | 6.30 Bn |
| 121 | TVTX | Travere Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.21 Bn | -142.87 | 10.50 | 6.09 Bn |
| 122 | BLTE | Belite Bio, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.15 Bn | 0.08 | — | 6.15 Bn |
| 123 | LQDA | Liquidia Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 6.14 Bn | 44.31 | 13.62 | 5.86 Bn |
| 124 | HOMB | Home Bancshares Inc | secondary | F-01 | Banking | FG-01 | 5.97 Bn | 12.46 | 129.11 | 4.92 Bn |
| 125 | AMRN | Amarin Corp Plc\Uk | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 5.96 Bn | -219.71 | 32.00 | 5.64 Bn |
| 126 | STWD | Starwood Property Trust, Inc. | secondary | F-08 | Lending and Credit | FG-02 | 5.83 Bn | 22.01 | 2.90 | 3.66 Bn |
| 127 | RUSHA | Rush Enterprises Inc \Tx\ | secondary | I-31 | Distribution and Rental | IG-07 | 5.76 Bn | 21.57 | 0.80 | 5.50 Bn |
| 128 | ASB | Associated Banc-Corp | secondary | F-01 | Banking | FG-01 | 5.69 Bn | 11.52 | 112.09 | 4.74 Bn |
| 129 | AUB | Atlantic Union Bankshares Corp | secondary | F-01 | Banking | FG-01 | 5.61 Bn | 11.79 | 3.64 | 4.52 Bn |
| 130 | ENVA | Enova International, Inc. | secondary | F-04 | Lending and Credit | FG-02 | 5.61 Bn | 15.77 | 1.63 | 5.48 Bn |
| 131 | RITM | Rithm Capital Corp. | secondary | F-08 | Lending and Credit | FG-02 | 5.52 Bn | 16.48 | 1.09 | 5.52 Bn |
| 132 | AMRX | Amneal Pharmaceuticals, Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 5.51 Bn | 25.57 | 1.77 | 5.38 Bn |
| 133 | HASI | HA Sustainable Infrastructure Capital, Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 4.90 Bn | 55.12 | 10.59 | 4.65 Bn |
| 134 | ERAS | Erasca, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.89 Bn | -17.03 | — | 4.89 Bn |
| 135 | FMCQF | Fresenius Medical Care AG | secondary | H-14 | Healthcare Providers | HG-04 | 4.79 Bn | 4.57 | 0.17 | 4.09 Bn |
| 136 | ACAD | Acadia Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.76 Bn | 12.50 | 4.18 | 3.80 Bn |
| 137 | EWTX | Edgewise Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.67 Bn | -23.69 | — | 4.67 Bn |
| 138 | SKY | Champion Homes, Inc. | secondary | D-09 | Homebuilding | DG-03 | 4.64 Bn | — | — | 4.00 Bn |
| 139 | MARA | MARA Holdings, Inc. | secondary | T-59 | Fintech | TG-09 | 4.53 Bn | -1.31 | 5.64 | 4.10 Bn |
| 140 | UCB | United Community Banks Inc | secondary | F-01 | Banking | FG-01 | 4.21 Bn | 11.36 | 3.79 | 3.67 Bn |
| 141 | DFTX | Definium Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.18 Bn | -11.83 | — | 4.18 Bn |
| 142 | INDV | Indivior Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.13 Bn | 11.63 | 3.10 | 3.91 Bn |
| 143 | DNLI | Denali Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 4.06 Bn | -7.94 | 1,126.80 | 4.06 Bn |
| 144 | OPLN | OPENLANE, Inc. | secondary | T-51 | Internet Platforms | TG-08 | 4.03 Bn | -47.27 | 1.94 | 3.84 Bn |
| 145 | MANE | Veradermics, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 4.00 Bn | -46.48 | — | 4.00 Bn |
| 146 | ABG | Asbury Automotive Group Inc | secondary | D-37 | Retail | DG-10 | 3.86 Bn | 7.58 | 0.21 | 3.83 Bn |
| 147 | CPRX | CATALYST PHARMACEUTICALS, INC. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.85 Bn | 17.94 | 6.45 | 3.09 Bn |
| 148 | ELVN | Enliven Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.80 Bn | -45.13 | — | 3.80 Bn |
| 149 | SKYW | Skywest Inc | secondary | I-18 | Transportation | IG-05 | 3.79 Bn | 9.24 | 0.90 | 3.19 Bn |
| 150 | RNST | Renasant Corp | secondary | F-01 | Banking | FG-01 | 3.70 Bn | 11.78 | 3.38 | 2.82 Bn |
| 151 | TARS | Tarsus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -76.58 | 5.93 | 3.14 Bn |
| 152 | OGN | Organon & Co. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | 17.20 | 0.59 | 2.46 Bn |
| 153 | RCUS | Arcus Biosciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 3.59 Bn | -7.79 | 30.64 | 2.88 Bn |
| 154 | SII | Sprott Inc. | secondary | F-09 | Asset and Wealth Management | FG-03 | 3.36 Bn | 31.97 | 8.39 | 3.16 Bn |
| 155 | FFBC | First Financial Bancorp /Oh/ | secondary | F-01 | Banking | FG-01 | 3.35 Bn | 11.74 | 3.32 | 3.35 Bn |
| 156 | BKU | BankUnited, Inc. | secondary | F-01 | Banking | FG-01 | 3.29 Bn | 12.01 | 138.61 | 2.92 Bn |
| 157 | IMNM | Immunome Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.96 Bn | -10.96 | 593.06 | 2.44 Bn |
| 158 | NRIX | Nurix Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.93 Bn | -8.57 | 79.61 | 2.48 Bn |
| 159 | NAMS | NewAmsterdam Pharma Co N.V. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.81 Bn | -10.83 | 394.49 | 2.81 Bn |
| 160 | HOG | Harley-Davidson, Inc. | secondary | D-04 | Automobiles and Components | DG-01 | 2.81 Bn | 14.35 | 0.66 | 0.91 Bn |
| 161 | ZLAB | Zai Lab Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.80 Bn | -14.90 | 6.24 | 2.10 Bn |
| 162 | CURLF | Curaleaf Holdings, Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 2.66 Bn | -22.42 | 2.03 | 2.56 Bn |
| 163 | FBNC | First Bancorp /Nc/ | secondary | F-01 | Banking | FG-01 | 2.64 Bn | 19.83 | 5.31 | 2.09 Bn |
| 164 | SLS | SELLAS Life Sciences Group, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.64 Bn | -81.36 | — | 2.64 Bn |
| 165 | TAK | Takeda Pharmaceutical Co Ltd | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.61 Bn | 4.54 | 0.06 | -3.19 Bn |
| 166 | BBT | Beacon Financial Corp | secondary | F-01 | Banking | FG-01 | 2.61 Bn | 16.32 | 82.24 | 1.39 Bn |
| 167 | TRVI | Trevi Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.60 Bn | -61.67 | — | 2.60 Bn |
| 168 | MLYS | Mineralys Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.59 Bn | -7.41 | — | 2.59 Bn |
| 169 | BEIGF | BeOne Medicines Ltd. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.48 Bn | 3.74 | 0.40 | -2.62 Bn |
| 170 | AGM | Federal Agricultural Mortgage Corp | secondary | F-05 | Lending and Credit | FG-02 | 2.45 Bn | 12.23 | 5.49 | 1.41 Bn |
| 171 | SUPN | Supernus Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -28.71 | 3.10 | 2.07 Bn |
| 172 | MBIN | Merchants Bancorp | secondary | F-01 | Banking | FG-01 | 2.41 Bn | 10.55 | 3.38 | 1.57 Bn |
| 173 | HRMY | Harmony Biosciences Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.41 Bn | 13.50 | 2.51 | 1.60 Bn |
| 174 | PBI | Pitney Bowes Inc /De/ | secondary | I-30 | Business Services | IG-06 | 2.36 Bn | 15.55 | 1.70 | 2.08 Bn |
| 175 | BHC | Bausch Health Companies Inc. | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 2.30 Bn | -2.11 | 0.21 | 0.46 Bn |
| 176 | PLUS | Eplus Inc | secondary | T-64 | Technology Services | TG-11 | 2.29 Bn | 16.03 | 0.91 | 1.84 Bn |
| 177 | BCRX | Biocryst Pharmaceuticals Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.29 Bn | -5.95 | 4.28 | 1.94 Bn |
| 178 | NUVB | Nuvation Bio Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.28 Bn | -21.11 | 13.44 | 2.28 Bn |
| 179 | BHVN | Biohaven Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.27 Bn | -3.87 | — | 2.00 Bn |
| 180 | TRN | Trinity Industries Inc | secondary | I-11 | Machinery | IG-02 | 2.24 Bn | 6.34 | 1.10 | 2.09 Bn |
| 181 | LTC | Ltc Properties Inc | secondary | R-07 | Property REITs | RG-01 | 2.21 Bn | 16.38 | 6.34 | 2.21 Bn |
| 182 | PVLA | Palvella Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.18 Bn | -41.21 | — | 1.87 Bn |
| 183 | AUPH | Aurinia Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 2.11 Bn | 6.70 | 6.76 | 1.66 Bn |
| 184 | TBBK | Bancorp, Inc. | secondary | F-02 | Banking | FG-01 | 2.08 Bn | 9.36 | 13.89 | 2.00 Bn |
| 185 | SRCE | 1St Source Corp | secondary | F-01 | Banking | FG-01 | 2.07 Bn | 12.10 | 69.78 | 2.07 Bn |
| 186 | BLX | Bladex, Inc. | secondary | F-01 | Banking | FG-01 | 2.06 Bn | 1.50 | 5.81 | 2.04 Bn |
| 187 | ZBIO | Zenas BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.03 Bn | -4.89 | 2,033.16 | 2.03 Bn |
| 188 | CMRE | Costamare Inc. | secondary | I-21 | Transportation | IG-05 | 1.80 Bn | 5.67 | 2.10 | 1.44 Bn |
| 189 | SMA | SmartStop Self Storage REIT, Inc. | secondary | R-08 | Property REITs | RG-01 | 1.76 Bn | 61.19 | 5.76 | 1.72 Bn |
| 190 | BY | Byline Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 1.69 Bn | 11.31 | 3.65 | 1.47 Bn |
| 191 | QCRH | Qcr Holdings Inc | secondary | F-01 | Banking | FG-01 | 1.67 Bn | 20.00 | 10.52 | 0.85 Bn |
| 192 | CASH | Pathward Financial, Inc. | secondary | F-02 | Banking | FG-01 | 1.67 Bn | 9.42 | 11.10 | 1.52 Bn |
| 193 | TRIN | Trinity Capital Inc. | secondary | F-07 | Lending and Credit | FG-02 | 1.64 Bn | 9.60 | 4.87 | 1.61 Bn |
| 194 | ETON | Eton Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.63 Bn | 170.39 | 16.23 | 1.60 Bn |
| 195 | IIPR | Innovative Industrial Properties Inc | secondary | R-04 | Property REITs | RG-01 | 1.62 Bn | 12.51 | 6.16 | 1.62 Bn |
| 196 | BC-PC | Brunswick Corp | secondary | D-04 | Automobiles and Components | DG-01 | 1.58 Bn | -40.64 | 0.28 | 1.27 Bn |
| 197 | TFIN | Triumph Financial, Inc. | secondary | F-01 | Banking | FG-01 | 1.57 Bn | 44.41 | 27.59 | 0.67 Bn |
| 198 | INVA | Innoviva, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.55 Bn | 7.91 | 3.01 | 0.97 Bn |
| 199 | AAPG | Ascentage Pharma Group International | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.54 Bn | -9.11 | 20.12 | 1.26 Bn |
| 200 | ANIP | Ani Pharmaceuticals Inc | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | 13.80 | 1.52 | 1.13 Bn |
| 201 | CSWC | Capital Southwest Corp | secondary | F-07 | Lending and Credit | FG-02 | 1.48 Bn | 21.29 | 6.23 | 1.42 Bn |
| 202 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.47 Bn | -3.17 | 2.04 | 1.17 Bn |
| 203 | LBRX | Lb Pharmaceuticals Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.43 Bn | -23.70 | — | 1.43 Bn |
| 204 | TRTN-PA | Triton International Ltd | secondary | I-11 | Machinery | IG-02 | 1.42 Bn | -2.78 | 19.72 | 1.42 Bn |
| 205 | AVBP | ArriVent BioPharma, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.42 Bn | -8.67 | — | 1.42 Bn |
| 206 | CNF | CNFinance Holdings Ltd. | secondary | F-05 | Lending and Credit | FG-02 | 1.41 Bn | -27.01 | 27.92 | 1.41 Bn |
| 207 | HROW | Harrow, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.41 Bn | -42.04 | 5.10 | 1.32 Bn |
| 208 | OMER | Omeros Corp | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.40 Bn | 82.16 | 36.50 | 1.40 Bn |
| 209 | TMP | Tompkins Financial Corp | secondary | F-01 | Banking | FG-01 | 1.40 Bn | 7.96 | 3.07 | 1.40 Bn |
| 210 | PEBO | Peoples Bancorp Inc | secondary | F-01 | Banking | FG-01 | 1.38 Bn | -40.68 | 54.63 | 1.20 Bn |
| 211 | GOLD | Gold.com, Inc. | secondary | D-36 | Retail | DG-10 | 1.36 Bn | 16.43 | 0.06 | 0.78 Bn |
| 212 | XERS | Xeris Biopharma Holdings, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.33 Bn | -77.52 | 3.97 | 1.21 Bn |
| 213 | GBX | Greenbrier Companies Inc | secondary | I-11 | Machinery | IG-02 | 1.32 Bn | 14.63 | 0.50 | 1.05 Bn |
| 214 | MSDL | Morgan Stanley Direct Lending Fund | secondary | F-07 | Lending and Credit | FG-02 | 1.25 Bn | 35.88 | 3.34 | 1.17 Bn |
| 215 | CRVS | Corvus Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.23 Bn | -25.77 | — | 1.02 Bn |
| 216 | WLFC | Willis Lease Finance Corp | secondary | I-01 | Aerospace and Defense | IG-01 | 1.20 Bn | 13.95 | 1.57 | 1.20 Bn |
| 217 | OPK | Opko Health, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.16 Bn | -30.70 | 1.98 | 0.86 Bn |
| 218 | OCSL | Oaktree Specialty Lending Corp | secondary | F-07 | Lending and Credit | FG-02 | 1.11 Bn | 20.56 | 2.45 | 1.07 Bn |
| 219 | OLMA | Olema Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.09 Bn | -5.32 | — | 1.09 Bn |
| 220 | KURA | Kura Oncology, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.08 Bn | -4.53 | 13.95 | 1.08 Bn |
| 221 | HTT | High Templar Tech Ltd | secondary | F-04 | Lending and Credit | FG-02 | 1.06 Bn | 10.80 | 186.91 | 0.16 Bn |
| 222 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.02 Bn | 69.58 | 1.37 | 0.77 Bn |
| 223 | NBBK | NB Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 1.01 Bn | 17.01 | 3.88 | 0.61 Bn |
| 224 | ESQ | Esquire Financial Holdings, Inc. | secondary | F-01 | Banking | FG-01 | 0.97 Bn | 18.43 | 6.09 | 0.73 Bn |
| 225 | MNPR | Monopar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.97 Bn | -70.03 | — | 0.92 Bn |
| 226 | LXRX | Lexicon Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.94 Bn | -15.00 | 22.74 | 0.75 Bn |
| 227 | DSGN | Design Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.93 Bn | -11.54 | — | 0.73 Bn |
| 228 | ABX | Abacus Global Management, Inc. | secondary | F-11 | Asset and Wealth Management | FG-03 | 0.91 Bn | 32.42 | 3.42 | 0.89 Bn |
| 229 | SGP | SpyGlass Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.91 Bn | -48.72 | — | 0.91 Bn |
| 230 | SMBK | Smartfinancial Inc. | secondary | F-01 | Banking | FG-01 | 0.86 Bn | 15.38 | 3.99 | 0.37 Bn |
| 231 | EGBN | Eagle Bancorp Inc | secondary | F-01 | Banking | FG-01 | 0.83 Bn | -17.25 | 2.77 | 0.83 Bn |
| 232 | PGC | Peapack Gladstone Financial Corp | secondary | F-01 | Banking | FG-01 | 0.81 Bn | 15.63 | 2.55 | 0.81 Bn |
| 233 | VSTM | Verastem, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.80 Bn | -6.91 | 9.10 | 0.66 Bn |
| 234 | CGBD | Carlyle Secured Lending, Inc. | secondary | F-07 | Lending and Credit | FG-02 | 0.80 Bn | 21.51 | 3.07 | 0.75 Bn |
| 235 | ACRS | Aclaris Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.79 Bn | -9.89 | 95.78 | 0.79 Bn |
| 236 | HTB | HomeTrust Bancshares, Inc. | secondary | F-01 | Banking | FG-01 | 0.78 Bn | 12.05 | 3.62 | 0.50 Bn |
| 237 | COLL | Collegium Pharmaceutical, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.75 Bn | 15.72 | 0.93 | 0.60 Bn |
| 238 | CTO | CTO Realty Growth, Inc. | secondary | R-03 | Property REITs | RG-01 | 0.75 Bn | 16.60 | 4.64 | 0.75 Bn |
| 239 | CUBB | Customers Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 0.74 Bn | 2.61 | 0.81 | -3.44 Bn |
| 240 | PHAT | Phathom Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.73 Bn | -7.42 | 3.04 | 0.54 Bn |
| 241 | ZVRA | Zevra Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.71 Bn | 12.24 | 5.24 | 0.49 Bn |
| 242 | PFIS | Peoples Financial Services Corp. | secondary | F-01 | Banking | FG-01 | 0.71 Bn | 12.47 | 53.99 | 0.22 Bn |
| 243 | GYRE | Gyre Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.70 Bn | -38.15 | 5.90 | 0.65 Bn |
| 244 | VEL | Velocity Financial, Inc. | secondary | F-05 | Lending and Credit | FG-02 | 0.70 Bn | 6.54 | -2.04 | -6.75 Bn |
| 245 | IVEVF | Inventiva S.A. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.69 Bn | 7.19 | 132.94 | 0.69 Bn |
| 246 | SLRC | SLR Investment Corp. | secondary | F-07 | Lending and Credit | FG-02 | 0.68 Bn | 7.61 | 3.24 | 0.68 Bn |
| 247 | LEGH | Legacy Housing Corp | secondary | D-09 | Homebuilding | DG-03 | 0.65 Bn | 12.62 | 3.60 | 0.62 Bn |
| 248 | AQST | Aquestive Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | -8.19 | 11.84 | 0.54 Bn |
| 249 | CRMD | CorMedix Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.64 Bn | 5.07 | 1.70 | 0.38 Bn |
| 250 | MPLT | MapLight Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.63 Bn | -3.10 | — | 0.63 Bn |
| 251 | OCS | Oculis Holding AG | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -340,055.90 | — | 0.60 Bn |
| 252 | NPB | Northpointe Bancshares Inc | secondary | F-01 | Banking | FG-01 | 0.59 Bn | 7.59 | 2.34 | 0.05 Bn |
| 253 | FBIZ | First Business Financial Services, Inc. | secondary | F-01 | Banking | FG-01 | 0.59 Bn | 10.76 | 3.31 | 0.42 Bn |
| 254 | MBNKO | Medallion Financial Corp | secondary | F-01 | Banking | FG-01 | 0.59 Bn | — | — | 0.45 Bn |
| 255 | NRIM | Northrim Bancorp Inc | secondary | F-01 | Banking | FG-01 | 0.58 Bn | 8.46 | 119.09 | 0.54 Bn |
| 256 | DCTH | Delcath Systems, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.58 Bn | 1,165.03 | 6.03 | 0.48 Bn |
| 257 | MSIF | Msc Income Fund, Inc. | secondary | F-07 | Lending and Credit | FG-02 | 0.57 Bn | 21.59 | 4.05 | 0.54 Bn |
| 258 | CIVB | Civista Bancshares, Inc. | secondary | F-01 | Banking | FG-01 | 0.56 Bn | 10.90 | 28.76 | 0.55 Bn |
| 259 | EOLS | Evolus, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -16.41 | 1.78 | 0.52 Bn |
| 260 | IRD | Opus Genetics, Inc. | secondary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -5.57 | 54.88 | 0.45 Bn |
| 261 | NVCT | Nuvectis Pharma, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.54 Bn | -17.80 | — | 0.54 Bn |
| 262 | OVID | Ovid Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.53 Bn | -15.37 | 334.91 | 0.41 Bn |
| 263 | SPRY | ARS Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.36 | 4.46 | 0.38 Bn |
| 264 | CSV | Carriage Services Inc | secondary | D-30 | Consumer Services | DG-09 | 0.50 Bn | 10.57 | 1.21 | 0.50 Bn |
| 265 | PRLD | Prelude Therapeutics Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -7.41 | 22.27 | 0.22 Bn |
| 266 | AHRT | AH Realty Trust, Inc. | secondary | R-03 | Property REITs | RG-01 | 0.48 Bn | -10.08 | 2.26 | 0.48 Bn |
| 267 | ANL | Adlai Nortye Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -10.27 | 78.36 | 0.23 Bn |
| 268 | XFOR | X4 Pharmaceuticals, Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.45 Bn | -4.99 | 28.37 | 0.25 Bn |
| 269 | PALI | Palisade Bio, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -12.43 | 877.24 | 0.31 Bn |
| 270 | IKT | Inhibikase Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -6.43 | — | 0.26 Bn |
| 271 | VTVT | vTv Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -87.86 | 11.34 | 0.42 Bn |
| 272 | SAJ | Saratoga Investment Corp. | secondary | F-07 | Lending and Credit | FG-02 | 0.41 Bn | -23.21 | 4.22 | 0.03 Bn |
| 273 | TTRX | Turn Therapeutics Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -52.78 | — | 0.41 Bn |
| 274 | FRST | Primis Financial Corp. | secondary | F-01 | Banking | FG-01 | 0.40 Bn | 7.52 | 1.77 | 0.22 Bn |
| 275 | EVMN | Evommune, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.14 | 39.23 | 0.19 Bn |
| 276 | OPRT | Oportun Financial Corp | secondary | F-04 | Lending and Credit | FG-02 | 0.38 Bn | 19.41 | 0.40 | 0.24 Bn |
| 277 | SNDL | SNDL Inc. | secondary | S-09 | Tobacco and Cannabis | SG-04 | 0.36 Bn | -17.72 | 0.54 | 0.23 Bn |
| 278 | DIN | Dine Brands Global, Inc. | secondary | D-17 | Restaurants | DG-06 | 0.35 Bn | 55.99 | 0.39 | 0.20 Bn |
| 279 | SION | Sionna Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.47 | — | 0.34 Bn |
| 280 | AVBH | Avidbank Holdings, Inc. | secondary | F-01 | Banking | FG-01 | 0.33 Bn | -23.65 | 20.04 | 0.17 Bn |
| 281 | ACHV | Achieve Life Sciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | — | — | 0.33 Bn |
| 282 | COSO | CoastalSouth Bancshares, Inc. | secondary | F-01 | Banking | FG-01 | 0.33 Bn | 12.01 | 161.24 | 0.29 Bn |
| 283 | VNDA | Vanda Pharmaceuticals Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.32 Bn | -1.15 | 1.47 | 0.15 Bn |
| 284 | FSBW | FS Bancorp, Inc. | secondary | F-01 | Banking | FG-01 | 0.32 Bn | 9.47 | 2.03 | 0.29 Bn |
| 285 | HRZN | Horizon Technology Finance Corp | secondary | F-07 | Lending and Credit | FG-02 | 0.31 Bn | 4.48 | 3.26 | 0.31 Bn |
| 286 | IMRX | Immuneering Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -5.02 | — | 0.30 Bn |
| 287 | EBS | Emergent BioSolutions Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -1.67 | 0.38 | 0.15 Bn |
| 288 | FULC | Fulcrum Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -3.29 | — | 0.29 Bn |
| 289 | FNRN | First Northern Community Bancorp | secondary | F-01 | Banking | FG-01 | 0.28 Bn | 12.53 | 103.73 | -0.09 Bn |
| 290 | RC | Ready Capital Corp | secondary | F-08 | Lending and Credit | FG-02 | 0.28 Bn | -0.49 | -49.18 | 0.28 Bn |
| 291 | RWAY | Runway Growth Finance Corp. | secondary | F-07 | Lending and Credit | FG-02 | 0.27 Bn | -2.93 | 2.06 | 0.26 Bn |
| 292 | ZNTL | Zentalis Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -1.94 | — | 0.27 Bn |
| 293 | AKBA | Akebia Therapeutics, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -8.70 | 1.18 | 0.10 Bn |
| 294 | ACRE | Ares Commercial Real Estate Corp | secondary | F-08 | Lending and Credit | FG-02 | 0.25 Bn | -55.63 | 4.47 | 0.21 Bn |
| 295 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.03 | 0.00 | -10.83 Bn |
| 296 | MRBK | Meridian Corp | secondary | F-01 | Banking | FG-01 | 0.23 Bn | 10.77 | 34.69 | 0.19 Bn |
| 297 | LIEN | Chicago Atlantic BDC, Inc. | secondary | F-07 | Lending and Credit | FG-02 | 0.23 Bn | 7.50 | 4.12 | 0.23 Bn |
| 298 | REFI | Chicago Atlantic Real Estate Finance, Inc. | secondary | F-08 | Lending and Credit | FG-02 | 0.23 Bn | 4.01 | — | 0.21 Bn |
| 299 | SIGA | Siga Technologies Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | — | — | 0.07 Bn |
| 300 | HQI | HireQuest, Inc. | secondary | I-25 | Business Services | IG-06 | 0.22 Bn | 31.96 | 7.26 | 0.22 Bn |